Joe McClung’s Post

Hankin Group recently welcomed Excision Medical, Inc. to Eagleview, joining Exton's thriving life sciences hub. Excision Medical is a privately held medical device company focused on structural heart technology innovations. Read more about the move in VISTA.Today: https://lnkd.in/ec-7_y-5 #RealEstateNews #LifeSciences

We’re excited to welcome COFORCE Medical to the Catcher family!   Previously part of GIMER Medical, 張季衡 Rex Chang, Wei-Ming Chen and their team bring with them deep experience in implantable neuromodulation R&D as well as CDMO capabilities, that provide comprehensive, customized, and integrated solutions. This marks a significant milestone in our relentless journey to become a leader in the medtech CDMO space while simultaneously maintaining a culture of innovation and excellence.   By integrating cross-disciplinary platforms that complement Catcher’s core strengths in material science and precision manufacturing, we strive to deliver ever greater value for our medtech partners and customers globally.   #CatcherMedical #PartnershipsforLife

Medtronic and Merit Medical Systems, Inc. continue to partner in the vertebral augmentation space today with the announcement of KyphoFlex. Two players coming together to offer what seems to be the best of their technologies. Without knowing the true ins and outs, it seems like a win for healthcare and for patients. Compatability between competitors to truly offer the best technology and flexibility in care. I think we will start to see a lot more of this in the future between companies that offer multicomponent solutions to patient problems. What do you think? #MedTech #MedicalDeviceSales #MedTechNews

Big News in MedTech! Expanse Medical is thrilled to announce that Jeff Hopkins has joined FlowPhysix, our spin-off company, as the new CEO and a member of the Board of Directors. With over 30 years in the medical device industry, Jeff's track record in innovation and growth is legendary. From Horizon Medical Products to Acclarent, he has led multiple companies to success, shaping the landscape of medical technology. Having worked with Jeff in the past, I have firsthand experience of his impactful leadership. FlowPhysix, formerly known as Expanse ICE, is poised to revolutionize the vascular market with its newly named FLOWRUNNER™ Aspiration System. With FDA clearance and strong clinical outcomes, we are ready for commercial launch. Jeff's proven leadership and commercialization acumen are exactly what we need during this exciting time of transformation and growth. Jeff Hopkins shares our vision of transforming treatments for vascular diseases. Under his guidance, we anticipate rapid adoption and enhanced patient outcomes worldwide. As Jeff says, "FLOWRUNNER will set new standards of care for clot removal, creating a new category of aspiration that works as physics intended." This solution will undoubtedly be a challenge to Inari and Pneumbra, pushing the boundaries of what's possible in the vascular market. To learn more about FlowPhysix and the innovative thrombectomy system, please visit our website flowphysix.com Congrats Jeff! Let's welcome Jeff aboard by commenting below. #MedTech #Innovation #Leadership

📺 STOCKHEAD INTERVIEW This week Orthocell Ltd announced the appointment of two new US-based executives as the Company prepares to enter the US market with its nerve repair product, Remplir™. Orthocell Chairman John Van Der Wielen spoke with Stockhead to share insights into why Remplir represents a compelling investment opportunity. Here's an excerpt: "The difference between Orthocell is you've got a product that's already been used in human bodies. There's over $35 million of cash on the balance sheet, and it's already in revenue with existing regulatory approval. It has crossed that threshold between this amazing concept and something that's actually generating revenue... it's a very low risk biotech compared to the majority of other smaller cap stocks. People are realising this is right on the threshold of coming into profit and significant growth." It's worth a look 👉 https://lnkd.in/giyF7DWT $OCC #Orthocell #nerverepair #medicaldevice #healthcare #medtech #innovation #growth #invest

Elucent Medical Inc., a medical technology company based in Eden Prairie, MN, received $30M in Growth financing from Trinity Capital. https://lnkd.in/g5r475rR

Belgian Firm Bedal Raises €10.2M for Catheter Securement Devices Exciting news in the medtech world! Diepenbeek-based Bedal International has successfully closed a €10.2M funding round to expand its innovative FlexGRIP catheter securement devices, enhancing patient care globally. This funding round, backed by prominent investors like White Fund, SFPIM, and notable US medtech investors, signifies strong confidence in Bedal's mission. Since its inception, Bedal has focused on developing securement solutions that prioritise patient comfort, addressing key challenges faced during intravenous catheter usage. The support from industry veterans and the recent appointment of Dr Steve Bierman as co-CEO promise a bright future for Bedal's growth and innovation. This new capital will accelerate Bedal's operational and commercial expansion, especially into the US market, further establishing FlexGRIP devices as a gold standard in catheter care. It's a thrilling chapter for Bedal, setting new benchmarks in medical devices with a profound impact on patients' lives. #Medtech #HealthcareInnovation #LifeSciences

MassDevice has news of Medtronic's latest tuck-in acquisition: Fortimedix Surgical B.V., developer of proprietary articulating instrument technology. Associate Editor Sean Whooley has the details. #medtech #meddevice #surgicalinstruments

𝐒𝐭𝐫𝐮𝐜𝐭𝐮𝐫𝐚𝐥 𝐇𝐞𝐚𝐫𝐭 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $25.69 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2029 🔶 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://lnkd.in/dDjejviF #NorthAmerica is one of the leading markets for structural heart devices due to its well-developed healthcare infrastructure, better hospitals, and special clinics that can quickly adopt and integrate new vascular technologies and treatments. Leading medical device manufacturers from the US, such as Edwards Lifesciences Corporation, Medtronic, Abbott, and Boston Scientific, ensure constant market growth owing to their continuous innovation and easy access to the latest and most significant devices. 🔶 𝐊𝐄𝐘 𝐏𝐋𝐀𝐘𝐄𝐑𝐒 𝐈𝐍 𝐓𝐇𝐄 𝐒𝐓𝐑𝐔𝐂𝐓𝐔𝐑𝐀𝐋 𝐇𝐄𝐀𝐑𝐓 𝐃𝐄𝐕𝐈𝐂𝐄𝐒 𝐌𝐀𝐑𝐊𝐄𝐓 𝐈𝐍𝐂𝐋𝐔𝐃𝐄: Edwards Lifesciences Boston Scientific Medtronic  Abbott  Cordis Cook Medical  W. L. Gore & Associates Teleflex  Integer Holdings Corporation  Lepu Medical Technology (Beijing) Co., Ltd. TTK  Artivion, Inc.  Venus Medtech SMT  Foldax Inc.  Micro Interventional Devices, Inc. Cardiac Dimensions

🌟 Exciting News in Medical Innovation! 🌟 In December 2024, AccuPath proudly announced its strategic investment in Perflow Medical, teaming up with Israeli technology to bolster R&D innovation in braiding. This collaboration will introduce advanced overseas technology, accelerating the implementation of state-of-the-art braiding technology and driving technological progress and industrial transformation in the medical sector. 🧵🩺 This investment will enhance the synergy and upgrade of advanced braiding technology between AccuPath and Perflow Medical, providing more accurate and dependable CDMO solutions for critical medical domains such as neurovascular intervention, aneurysm treatment, and intracranial atherosclerosis. Join us in shaping the future of healthcare!   #AccuPath # PerflowMedical #MedicalTech #InnovationCollaboration